MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that DNAnexus users now have access to the International Cancer Genomes Consortium (ICGC) Dataset, consisting of data from more than 2,400 whole human cancer genomes from over 1,100 unique ICGC donors.
The Ontario Institute for Cancer Research (OICR) is a translational research center and a founding member of the ICGC, housing the Data Coordination Centre for the Consortium. The ICGC dataset represents hundreds of terabytes of interpreted and raw data, which is hosted on Amazon Web Services (AWS). The data will be used to explore the genomic basis of cancer, accelerate research, and develop more targeted therapies. In addition to the raw data, the dataset contains a total of nearly four million identified mutations, many affecting known cancer-causing genes.
With the ICGC data now available on AWS, researchers globally at institutions large and small will be able to access this large dataset easily on the DNAnexus Platform, easing the technical and computational barriers for cancer genomics analysis and data sharing.
“The confluence of massive bioinformatics datasets and a culture of increased collaboration, makes this the ideal time to move to a cloud computing environment,” said Dr. Lincoln Stein, Program Director of OICR’s Informatics and Bio-computing Program and Director of the ICGC’s Data Coordination Centre. “The combination of the DNAnexus Platform and AWS means that our data is secure, compliant, and easily shared with our collaborators.”
“The researchers involved in the ICGC project have worked tirelessly to create an unprecedented collection of genomic data that has the potential to advance cancer research and enable the discovery of new treatments. DNAnexus provides a global network for genomic medicine, allowing researchers from around the world to share data, perform sophisticated analysis and extract new insights into the disease in a way that previously wasn’t possible,” said Richard Daly, CEO of DNAnexus.
By providing the global network for genomic medicine, DNAnexus has removed barriers to genomic insight and is advancing precision medicine. Researchers can collaborate across national borders without geographic boundaries, share and analyze data together regardless of organizational affiliation, and not have to invest in additional IT infrastructure to support large scale analysis.
DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomic medicine. DNAnexus provides security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health in order to accelerate medical discovery. DNAnexus is supporting customers around the world that are tackling some of the most challenging and exciting opportunities in human health. For more information please visit: https://dnanexus.com and follow us at @DNAnexus.